SET pseudogene 17 (SETP17)

SET pseudogene 17 is a genomic sequence classified as a pseudogene, meaning it is highly similar to another gene (likely SET) but lacks protein-coding capability due to disabling mutations such as frameshifts or premature stop codons[5][1][2]. As with other pseudogenes, SETP17 does not produce a functional protein, and no evidence indicates any direct biological or pathological role or that it is a valid molecular drug target[5][1][2]. While *some* pseudogenes elsewhere in the genome have acquired secondary regulatory functions (for example, by acting as competitive endogenous RNAs or regulating gene networks in rare cases), there is no reported evidence for a functional or therapeutic role for SET pseudogene 17[5][1][2][3][4][7]. Key points: - **SETP17 is not a receptor, enzyme, transporter, or other canonical drug target, and should not be considered a valid therapeutic target.** - **No drugs, mechanisms of action, or disease biomarker roles have been identified for SETP17**[5]. - Its presence as a pseudogene means it is best described as a nonfunctional, noncoding genomic remnant. If you are seeking a drug target or protein function, this entry is likely a misidentification or a misunderstanding: SETP17 itself does not function as a molecular target[5]. If you meant the functional **SET gene** or a related protein, further specification is needed.

Other names

SET pseudogene 17SETP17